> ## Content Index
> Fetch the complete content index at: https://www.tidemetrix.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Kentucky maintains compounding restrictions on six peptides despite federal policy
- URL: https://www.tidemetrix.com/kentucky-maintains-compounding-restrictions-on-six-peptides-despite-federal-policy/
- Published: 2026-11-19T11:00:00.000Z
- Updated: 2026-11-20T11:03:10.000Z
- Description: Kentucky's decision highlights the limits of federal enforcement discretion, adding another layer of regulatory complexity for peptide API suppliers and compounding pharmacies serving the US market.
- Author: TideMetrix Editorial
- Tags: Regulation, APIs, United States, #brief

Kentucky's Board of Pharmacy has declined to waive existing ingredient restrictions for six peptides, maintaining restrictions on compounding and shipments into the state despite the federal enforcement-discretion policy.

A November 19 compliance alert documents the board's November 18 decision to enforce existing state regulations (201 KAR 2:076). The six peptides affected are BPC-157, TB-500, epitalon, semax, KPV and MOTS-c.

According to the board, none meets Kentucky's ingredient eligibility criteria: an applicable US Pharmacopeia or National Formulary monograph, use as a component of an FDA-approved human drug, or inclusion on the FDA's 503A bulks list.

The board maintains that federal enforcement discretion neither changes these criteria nor overrides state law.

The alert directs pharmacies not to compound, dispense or ship affected preparations in or into Kentucky. The requirements also apply to licensed out-of-state pharmacies serving Kentucky customers.

Pharmacies must segregate affected inventory and document ingredient eligibility before compounding.

The decision represents enforcement of existing state regulations rather than the introduction of new restrictions. The board says it will continue to monitor FDA rulemaking.

### Sources

- [Kentucky Board of Pharmacy — compliance alert, November 19, 2026](https://pharmacy.ky.gov/Documents/Frankfort%2C%20KY.%2011.19.26%20Compliance%20Alert%20Compounding%20With%20Peptide%20Bulk%20Drug%20Substances%20Under%20the%20HHS%20Enforcement%20Discretion%20Policy.pdf?ref=tidemetrix.com)